Skip to main content
Clinical Trials/IRCT20200412047048N1
IRCT20200412047048N1CompletedPhase 3

Assessing the Effect of Oral Monte Locasta Compared with Pharmacology in Asthma Attacks, In addition to the common treatment of asthma attacks as a two-course, an accident in children aged 1-14 years with asthma

Tehran University of Medical Sciences0 sites100 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 year to 14 years (—)
Sex
All

Inclusion Criteria

  • All patients aged 1-14 years who are confirmed based on history and examination for asthma attack

Exclusion Criteria

  • Those with a history of taking corticosteroids or montelukast for the past ten days
  • All patients who developed a diagnosis other than asthma, such as pneumonia or bronchiolitis

Investigators

Similar Trials